Concept

Ecstasy

OpenAlex ID: C2779488553

The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)

2003 · A. Richard Green, Annis O. Mechan, et al. · Pharmacological Reviews · 1,272

Shamanism: Archaic Techniques of Ecstasy

1964 · Ilza Veith · JAMA · 1,137

Amphetamines and related compounds

1971 · Edward F. Domino · Electroencephalography and Clinical Neurophysiology · 927

PDF

The Ecstasy of Communication

2007 · Jean Baudrillard, John Johnston · SAGE Publications Ltd eBooks · 924

Non‐medical use of prescription stimulants among US college students: prevalence and correlates from a national survey

2004 · Sean Esteban McCabe, John R. Knight, et al. · Addiction · 885

PDF

Shamanism: Archaic Techniques of Ecstasy

1951 · Mircéa Éliade · Medical Entomology and Zoology · 884

International review of studies on emotion

1991 · K. T. Strongman · Medical Entomology and Zoology · 852

Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")

1992 · J.A. Henry, K.J. Jeffreys, et al. · The Lancet · 729

Altered Brain Serotonin Homeostasis and Locomotor Insensitivity to 3,4-Methylenedioxymethamphetamine (“Ecstasy”) in Serotonin Transporter-Deficient Mic

1998 · Dietmar Bengel, Dennis L. Murphy, et al. · Molecular Pharmacology · 719

The Toxicology of Bath Salts: A Review of Synthetic Cathinones

2011 · Jane M. Prosser, Lewis S. Nelson · Journal of Medical Toxicology · 706

PDF

Positron emission tomographic evidence of toxic effect of MDMA (“Ecstasy”) on brain serotonin neurons in human beings

1998 · UD McCann, Z Szabo, et al. · The Lancet · 660

The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs.

2001 · H Kalant · PubMed · 612

The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release.

1992 · G Rudnick, S C Wall · Proceedings of the National Academy of Sciences · 535

Minority Stress and Substance Use in Sexual Minority Adolescents: A Meta-analysis

2013 · Jeremy T. Goldbach, Emily E. Tanner-Smith, et al. · Prevention Science · 512

Comparing illicit drug use in 19 European cities through sewage analysis

2012 · Kevin V. Thomas, Lubertus Bijlsma, et al. · The Science of The Total Environment · 493

PDF

Alcohol and drug use in UK university students

1996 · E Webb, CH Ashton, et al. · The Lancet · 472

Understanding reasons for drug use amongst young people: a functional perspective

2001 · A. Boys · Health Education Research · 463

Psychological and Cardiovascular Effects and Short-Term Sequelae of MDMA (“Ecstasy”) in MDMA-Naïve Healthy Volunteers

1998 · Franz X Vollenweider, Alex Gamma, et al. · Neuropsychopharmacology · 448

Human Pharmacology of MDMA

2004 · Rafael de la Torre, Magí Farré, et al. · Therapeutic Drug Monitoring · 444

The Designer Methcathinone Analogs, Mephedrone and Methylone, are Substrates for Monoamine Transporters in Brain Tissue

2011 · Michael H Baumann, Mario A Ayestas, et al. · Neuropsychopharmacology · 439

PDF

Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or “Ecstasy”)

1995 · A. R. Green, A. J. Cross, et al. · Psychopharmacology · 415

Recreational MDMA use in Sydney: a profile of ‘Ecstasy’ users and their experiences with the drug

1992 · NADIA SOLOWIJ, WAYNE HALL, et al. · British Journal of Addiction · 413

Subjective Reports of the Effects of MDMA in a Clinical Setting

1986 · George Greer, Requa Tolbert · Journal of Psychoactive Drugs · 413

Clubbing : dancing, ecstasy and vitality

1999 · Ben Malbon · 412

Non‐linear pharmacokinetics of MDMA (‘ecstasy’) in humans

2000 · R. De La Torre, M. Farré, et al. · British Journal of Clinical Pharmacology · 401

PDF

Works count: 10,870

Citation count: 203,600